Meeting of the Tick-Borne Disease Working Group, 30182-30183 [2018-13812]

Download as PDF 30182 Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices • Creating a more efficient review strategy for evaluating qualified health claims on food labels. • Discussing new or enhanced labeling statements or claims that could facilitate innovation to produce more healthful foods and more healthful consumer food choices. • Modernizing the standards of identity to provide more flexibility for the development of healthier products, while making sure consumers have accurate information about these food products. • Providing opportunities to make ingredient information more helpful to consumers. • FDA’s educational campaign for consumers about the updated Nutrition Facts Label. We invite interested parties to provide information on the above and other topics related to the FDA Nutrition Innovation Strategy. III. Participating in the Public Meeting Registration: To register for the public meeting, please visit the following website: https://www.fda.gov/Food/ NewsEvents/WorkshopsMeetings Conferences/default.htm. Please provide complete contact information for each attendee, including name, title, affiliation, address, email, and telephone. Registration is free and based on space availability, with priority given to early registrants. Persons interested in attending this public meeting must register by July 19, 2018, midnight Eastern Time. Early registration is recommended because seating is limited; therefore, FDA may limit the number of participants from each organization. Registrants will receive confirmation when they have been accepted. If you need special accommodations due to a disability, please contact Juanita Yates (see FOR FURTHER INFORMATION CONTACT) no later than July 12, 2018. Requests for Oral Presentations: During online registration you may indicate if you wish to present during a public comment session or participate in a specific session, and which topic(s) you wish to address. We will do our best to accommodate requests to make public comments and requests to participate in the focused sessions. Individuals and organizations with common interests are urged to consolidate or coordinate their presentations, and request time for a joint presentation, or submit requests for designated representatives to participate in the focused sessions. All requests to make oral presentations must be received by July 12, 2018, midnight Eastern Time. We will determine the amount of time allotted to each presenter and the approximate time each oral presentation is to begin, and will select and notify participants by July 16, 2018. Speakers will be limited to making oral remarks; there will not be an opportunity to display materials such as slide shows, videos, or other media during the meeting. No commercial or promotional material will be permitted to be presented or distributed at the public meeting. Streaming Webcast of the Public Meeting: This public meeting will also be webcast. Webcast participants are asked to preregister at https:// www.fda.gov/Food/NewsEvents/ WorkshopsMeetingsConferences/ default.htm. Transcripts: Please be advised that as soon as a transcript of the public meeting is available, it will be accessible at https://www.regulations.gov. It may be viewed at the Dockets Management Staff (see ADDRESSES). A link to the transcript will also be available on the internet at https://www.fda.gov/Food/ NewsEvents/WorkshopsMeetings Conferences/default.htm. Other Issues for Consideration: A summary of key information on participating in the meeting follows: TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING Date Preregister Electronic address Request to make an oral presentation July 19, 2018: Closing date for registration. https://www.fda.gov/ Food/ NewsEvents/ WorkshopsMeetingsConferences/ default.htm. July 12, 2018 ......... Address July 26, 2018 from 8:30 a.m. until 5:30 p.m. EDT. Hilton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852. Dated: June 22, 2018. Leslie Kux, Associate Commissioner for Policy. seventh meeting of the Tick-Borne Disease Working Group (Working Group) on July 24, 2018, from 10:00 a.m. to 4:00 p.m., Eastern Time. The seventh meeting will be an on-line meeting held via webcast. The Working Group will review and vote on the content of the five chapters that will be included in the Working Group’s Report to Congress. [FR Doc. 2018–13831 Filed 6–26–18; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Tick-Borne Disease Working Group Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. daltland on DSKBBV9HB2PROD with NOTICES AGENCY: The Department of Health and Human Services (HHS) announces the SUMMARY: VerDate Sep<11>2014 16:58 Jun 26, 2018 Jkt 244001 The on-line meeting will be held on July 24, 2018, from 10:00 a.m. to 4:00 p.m. Eastern Time. DATES: This will be an on-line meeting that is held via webcast. Members of the public may attend the meeting via webcast. Instructions for attending this virtual meeting will be posted prior to the meeting at: https:// ADDRESSES: PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 Special accommodations Submit either electronic or written comments July 12, 2018: clos- Submit Comments to: https:// ing date to rewww.regulations.gov, or quest special acDockets Management Staff commodations (HFA–305), Food and Drug due to a disability. Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. www.hhs.gov/ash/advisory-committees/ tickbornedisease/meetings/. FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services; via email at tickbornedisease@ hhs.gov or by phone at 202–795–7697. SUPPLEMENTARY INFORMATION: The Working Group invites public comment on issues related to the Working Group’s charge. Comments may be provided over the phone during the meeting or in writing. Persons who wish to provide comments by phone should review directions at https://www.hhs.gov/ash/ advisory-committees/tickbornedisease/ meetings/ before submitting a request via email at tickbornedisease@ hhs.gov on or before July 19, 2018. E:\FR\FM\27JNN1.SGM 27JNN1 Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Notices Phone comments will be limited to three minutes each to accommodate as many speakers as possible. A total of 30 minutes will be allocated to public comments. If more requests are received than can be accommodated, speakers will be randomly selected. The nature of the comments will not be considered in making this selection. Public comments may also be provided in writing. Individuals who would like to provide written comment should review directions at https://www.hhs.gov/ash/ advisory-committees/tickbornedisease/ meetings/ before sending their comments to tickbornedisease@ hhs.gov on or before July 19, 2018. During the meeting, the Working Group will review and vote on the content of the five draft chapters that will be included in the Working Group’s Report to Congress. Persons who wish to receive the draft chapters should email the tickbornedisease@hhs.gov and request a copy. The chapters will be available prior to the meeting. Background and Authority: The TickBorne Disease Working Group was established on August 10, 2017, in accordance with section 2062 of the 21st Century Cures Act, and the Federal Advisory Committee Act, 5 U.S.C. App., as amended, to provide expertise and review all HHS, DoD and VA efforts related to tick-borne diseases to help ensure interagency coordination and minimize overlap, examine research priorities, and identify and address unmet needs. In addition, the Working Group is required to submit a report to the Secretary and Congress on their findings and any recommendations for improving the federal response to tickborne disease prevention, treatment and research, and addressing gaps in those areas. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health daltland on DSKBBV9HB2PROD with NOTICES [FR Doc. 2018–13788 Filed 6–26–18; 8:45 am] BILLING CODE 4140–01–P National Eye Institute; Notice of Closed Meeting BILLING CODE 4150–28–P Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. Jkt 244001 Dated: June 21, 2018. Michelle D. Trout, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2018–13812 Filed 6–26–18; 8:45 am] 16:58 Jun 26, 2018 Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Multiple Study Data Coordinating Centers for Division of Intramural Population Health Research (DIPHR). Date: July 30, 2018. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6710 B Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Sathasiva B. Kandasamy, Ph.D., Scientific Review Administrator, Division of Scientific Review. National Institute of Child Health and Human Development, 6710B Rockledge Drive, Bethesda, MD 20892, (301) 435–6680, skandasa@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: June 22, 2018. James Berger, Designated Federal Officer, Office of HIV/ AIDS and Infectious Disease Policy, TickBorne Disease Working Group. VerDate Sep<11>2014 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 30183 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI Pathways To Independence (K99) and Conference (R13) Grant Applications. Date: July 23–24, 2018. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5635 Fishers Lane, Bethesda, MD 20892. Contact Person: Zhihong Shan, MD, Ph.D., Scientific Review Officer (Contractor), Division of Extramural Activities, National Eye Institute, National Institute of Health, 5635 Fishers Lane, Suite 1300, Bethesda, MD 20892, 301–435–1779, zhihong.shan@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: June 22, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–13844 Filed 6–26–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Integrative Health; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Complementary and Integrative Health. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Complementary and Integrative Health. Date: August 15, 2018. Closed: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Partap Singh Khalsa, Ph.D., DC, Director, Division of Extramural Activities, National Center for E:\FR\FM\27JNN1.SGM 27JNN1

Agencies

[Federal Register Volume 83, Number 124 (Wednesday, June 27, 2018)]
[Notices]
[Pages 30182-30183]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13812]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) announces 
the seventh meeting of the Tick-Borne Disease Working Group (Working 
Group) on July 24, 2018, from 10:00 a.m. to 4:00 p.m., Eastern Time. 
The seventh meeting will be an on-line meeting held via webcast. The 
Working Group will review and vote on the content of the five chapters 
that will be included in the Working Group's Report to Congress.

DATES: The on-line meeting will be held on July 24, 2018, from 10:00 
a.m. to 4:00 p.m. Eastern Time.

ADDRESSES: This will be an on-line meeting that is held via webcast. 
Members of the public may attend the meeting via webcast. Instructions 
for attending this virtual meeting will be posted prior to the meeting 
at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/.

FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and 
Infectious Disease Policy, Office of the Assistant Secretary for 
Health, Department of Health and Human Services; via email at 
[email protected] or by phone at 202-795-7697.

SUPPLEMENTARY INFORMATION: The Working Group invites public comment on 
issues related to the Working Group's charge. Comments may be provided 
over the phone during the meeting or in writing. Persons who wish to 
provide comments by phone should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/ before submitting a request via email at 
[email protected] on or before July 19, 2018.

[[Page 30183]]

Phone comments will be limited to three minutes each to accommodate as 
many speakers as possible. A total of 30 minutes will be allocated to 
public comments. If more requests are received than can be 
accommodated, speakers will be randomly selected. The nature of the 
comments will not be considered in making this selection. Public 
comments may also be provided in writing. Individuals who would like to 
provide written comment should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/ before sending their comments to [email protected] on 
or before July 19, 2018.
    During the meeting, the Working Group will review and vote on the 
content of the five draft chapters that will be included in the Working 
Group's Report to Congress. Persons who wish to receive the draft 
chapters should email the [email protected] and request a copy. 
The chapters will be available prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review all HHS, DoD 
and VA efforts related to tick-borne diseases to help ensure 
interagency coordination and minimize overlap, examine research 
priorities, and identify and address unmet needs. In addition, the 
Working Group is required to submit a report to the Secretary and 
Congress on their findings and any recommendations for improving the 
federal response to tick-borne disease prevention, treatment and 
research, and addressing gaps in those areas.

    Dated: June 22, 2018.
James Berger,
 Designated Federal Officer, Office of HIV/AIDS and Infectious Disease 
Policy, Tick-Borne Disease Working Group.
[FR Doc. 2018-13812 Filed 6-26-18; 8:45 am]
BILLING CODE 4150-28-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.